MSN to launch generic anti-COVID pill Molnupiravir Medical Dialogues Bureau8 Jan 2022 9:45 AM ISTNew Delhi: Pharmaceuticals firm MSN Group on Thursday said it will launch its generic anti-COVID-19 pill Molnupiravir under the brand 'Molulow' in...
CII pitches for coordinated actions by Centre, states to minimize Omicron impact Medical Dialogues Bureau7 Jan 2022 2:16 PM ISTNew Delhi: Amid fears that the new coronavirus variant may disrupt normal business activity, industry chamber CII on Thursday pitched for coordinated...
Tata Medical and Diagnostics develops kit to detect Omicron variant in RT-PCR tests Medical Dialogues Bureau7 Jan 2022 2:15 PM ISTNew Delhi: The Tata Medical and Diagnostics has developed a kit 'OmiSure' that can detect the Omicron variant of SARS-CoV2 in...
Medical device maker Stryker to buy Vocera Communications for 2.97 Billion USD Medical Dialogues Bureau7 Jan 2022 9:30 AM ISTNew Delhi: Medical device maker Stryker Corp said on Thursday it had agreed to acquire digital care platform Vocera Communications Inc (VCRA.N) for...
Aurobindo Pharma launches COVID-19 drug Molnupiravir Medical Dialogues Bureau7 Jan 2022 9:00 AM ISTHYDERABAD: Aurobindo Pharma Limited has launched COVID-19 treatment drug Molnupiravir under brand name "Molnaflu" in India.Molnupiravir is for...
Alembic Pharma receives USFDA Final Approval for Entacapone Tablets USP, 200 mg Medical Dialogues Bureau6 Jan 2022 3:27 PM ISTMumbai: Alembic Pharmaceuticals Limited (Alembic) today announced that it has received final approval from the US Food & Drug Administration...
No painkillers or paracetamol recommended after Covaxin jab: Bharat Biotech Medical Dialogues Bureau6 Jan 2022 12:03 PM ISTNew Delhi: Bharat Biotech on Wednesday said no painkillers or paracetamol are recommended after being vaccinated with its COVID-19 vaccine...
French court backs class action against Sanofi over Depakine drug Medical Dialogues Bureau6 Jan 2022 11:52 AM ISTPARIS: A French court ruled on Wednesday that families of victims of Depakine, an epilepsy drug that caused birth defects and learning difficulties...
Zydus Cadila Announces COVID-19 Vaccine Expansion Plan to Multiple Countries With Korean Firm Medical Dialogues Bureau6 Jan 2022 11:52 AM ISTGOLDEN: PharmaJet®, the maker of innovative, needle-free injection technology, today announced that its partner Zydus Cadila, is partnering with...
Tamil Nadu to get Medical Device Parks Medical Dialogues Bureau6 Jan 2022 5:45 AM ISTChennai: The Tamil Nadu government is setting up a medical devices park and a furniture park in the state, Governor R N Ravi told the State Assembly...
Novartis wins appeal over MS drug Gilenya patent: Bloomberg Medical Dialogues Bureau5 Jan 2022 10:00 AM ISTThe issue on appeal was whether the patent clearly explained the dosage regimen for fingolimod, the active ingredient in Gilenya, without the need for...
KVS Ram Rao appointed Granules India Joint MD, CEO Medical Dialogues Bureau5 Jan 2022 9:30 AM ISTRao has previously worked at various companies like Dr Reddys Laboratories, Jubilant Life Sciences and Gujarat Heavy Chemicals.
